Skip to main content
SpringerLink
Log in
Book cover

31st Hemophilia Symposium Hamburg 2000 pp 153–158Cite as

Progression of Thrombosis under Low Molecular Weight Heparin without Heparin-Induced Thrombocytopenia in a young Man: a Case Report

  • Conference paper

  • 106 Accesses

Abstract

Low molecular weight heparins (LMWHs) have been proven to be efficacious and safe in the treatment and prophylaxis of thrombosis in adults. LMWHs also appear to offer a safe and effective form of anticoagulation in children [5,9,13,15], but in contrast to adults randomized clinical trials comparing LMWHs with unfractionated heparins (UFHs) and vitamin K antagonists for the prevention and treatment of thromboembolic events are lacking. According to clinical experiences with LMWHs in children [5,9,11,15] for prophylaxis of thrombosis plasma anti-Xa activities between 0.2 and 0.4 IU/ml measured 4 h after application are needed for effective prevention of thrombus apposition or recurrence of thrombosis. We report on a 16-year-old boy who suffered from an incomplete thrombosis of the left popliteal vein and developed an extended complete vein thrombosis during secondary thrombosis prophylaxis with nadroparin. At that time the anti-Xa activity was in the prophylactic range, the patient wore a compression stocking and was completely mobilized.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bianchetti MG, Speck S, Müller R, Oetliker OH. Simple coagulation prophylaxis using low-molecular heparin enoxaparin in pediatric hemodialysis. Schweiz Rundsch Med Prax 1990; 79: 730–731

    PubMed  CAS  Google Scholar 

  2. Broyer M, Gagnadoux MF, Sierro A, Fischer AM, Révillon Y, Jan D, Beurton D, Niaudet P. Prevention of vascular thromboses after renal transplantation using low molecular weight heparin. Ann Pediatr (Paris) 1991; 38: 397–9

    CAS  Google Scholar 

  3. Collignon F, Frydman A, Caplain H, Ozoux ML, Le Roux Y, Bouthler J, Thebault JJ. Comparison of pharmacokinetic profiles of three low molecular mass heparins-dalteparin, enoxaparin and nadroparin–administered subcutaneously in healthy volunteers (doses for prevention of thromboembolism). Thromb Haemost 1995; 73: 630–640

    PubMed  CAS  Google Scholar 

  4. de Veber G, Chan A, Monagle P, Marzinotto V, Armstrong D, Massicotte P, Leaker M, Andrew M. Anticoagulation therapy in pediatric patients with sinovenous thrombosis: a cohort study. Arch Neurol 1998; 55: 1533–1537

    Article  Google Scholar 

  5. Dix D, Andrew M, Marzinotto V, Charpentier K, Bridge S, Monagle P, de Veber G, Leaker M, Chan AKC, Massicotte MP. The use of low molecular weight heparin in pediatric patients: A prospective cohort study. J Pediatr 2000; 136: 439–445

    Article  PubMed  CAS  Google Scholar 

  6. Gagnadoux MF, Charbit M, Beurton D, Revillon Y, Niaudet P, Broyer M. Renal transplantation in children under five years of age. Experience at the Hopital des Enfants-Malades. Ann Pediatr (Paris) 1993; 40: 108–111

    CAS  Google Scholar 

  7. Greinacher A. Heparin-induced thrombocytopenia-pathogenesis and treatment. Thromb Haemost 1999; 82 (Suppl): 148–156

    PubMed  Google Scholar 

  8. Hashikura Y, Kawasaki S, Okumura N, Ishikawa S, Matsunami H, Ikegami T, Nakazawa Y, Makuuchi M. Prevention of hepatic artery thrombosis in pediatric liver transplantation. Transplantation 1995; 60: 1109–1112

    Article  PubMed  CAS  Google Scholar 

  9. Hofmann S, Knöfler R, Wendisch J, Siegert G, Müller D, Taut-Sack H, Dinger J, Lorenz N, Tittel B, Kabus M. Clinical experiences with low molecular weight heparins in pediatric patients. Eur J Pediatr 1999; 158 (Suppl 3): S219

    Google Scholar 

  10. Klement D, Rammos S, von Kries R, Kirschke W, Kniemeyer HW, Greinacher A. Heparin as a cause of thrombus progression. Eur J Pediatr 1996; 155: 11–14

    PubMed  CAS  Google Scholar 

  11. Kosch A, von Kries R, Nowak-Göttl U. Thrombosen im Kindesalter. Monatsschr Kinderheilkd 2000; 148: 387–397

    Article  Google Scholar 

  12. Lopaciuk S, Bielska-Falda H, Noszczyk W, Bielawiec M, Witkiewicz W, Filipecki S, Michalak J, Ciesielski L, Mackiewicz Z, Czestochowska E, Zawilska K, Cencora A. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis. Thromb Haemost 1999; 81: 26–31

    PubMed  CAS  Google Scholar 

  13. Massicotte P, Adams M, Marzinotto V, Brooker LA, Andrew M. Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding study. J Pediatr 1996; 128: 313–318

    Article  PubMed  CAS  Google Scholar 

  14. Monreal M, Lafoz E, Olive A, del Rio L, Vedia C. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Thromb Haemost 1994; 71: 7–11

    PubMed  CAS  Google Scholar 

  15. Nohe N, Flemmer A, Rümler R, Praun M, Auberger K. The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases. Eur J Pediatr 1999; 158 (Suppl 3): S134 - S139

    Article  PubMed  CAS  Google Scholar 

  16. Nowak-Göttl U, Ehrenforth S, Koch HG, Kreuz W, Münchow N, Scharrer I, Schneppenheim R. Multicenter evaluation of combined prothrombotic defects in childhood thromboembolism. In: 28. Hämophilie-Symposion Hamburg 1997. Scharrer I, Schramm W, Eds. Springer 1999; 105–116

    Google Scholar 

  17. Pini M, Aiello S, Manotti C, Pattacini C, Quintavalla R, Poli T, Tagliaferri A, Dettori AG. Low molecular weight heparin versus warfarin in the prevention of recurrence after deep vein thrombosis. Thromb Haemost 1994; 72: 191–197

    PubMed  CAS  Google Scholar 

  18. Severin T, Ensenauer R, Wiedensohler A, Fischer KG, Zieger B, Greinacher A, Brandis M, Sutor AH. HIT type II without thrombocytopenia in a 15-year-old boy with protein S deficiency and recurrent deep vein thrombosis. In: 29. Hämophilie-Symposion Hamburg 1999. Scharrer I, Schramm W, Eds., Springer 2001; 114–116

    Chapter  Google Scholar 

  19. Streif W, Mitchell LG, Andrew M. Antithrombotic therapy in children. Curr Opin Pediatr 1999; 11: 56–64

    Article  PubMed  CAS  Google Scholar 

  20. Van Biljon I, Van Damme Lombaerts R, Demol A, Van Geet C, Proesmans W, Arnout J. Low molecular weight heparin for anticoagulation during haemodialysis in children - a preliminary study [letter]. Eur J Pediatr 1996; 155: 70

    PubMed  Google Scholar 

Download references

Authors
  1. R. Knöfler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Wendisch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Nemat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Siegert
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Gehrisch
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Schellong
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hemophilia Center, Dept. of Internal Medicine, University Hospital, Theodor-Stern-Kai 7, D-60590, Frankfurt am Main, Germany

    Inge Scharrer

  2. Dept. of Hemostasiology, University Hospital, Ziemssenstr. 1a, D-80336, München, Germany

    Wolfgang Schramm

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Knöfler, R., Wendisch, J., Nemat, K., Siegert, G., Gehrisch, S., Schellong, S. (2002). Progression of Thrombosis under Low Molecular Weight Heparin without Heparin-Induced Thrombocytopenia in a young Man: a Case Report. In: Scharrer, I., Schramm, W. (eds) 31st Hemophilia Symposium Hamburg 2000. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59383-3_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59383-3_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42131-3

  • Online ISBN: 978-3-642-59383-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation